CCR2 antagonists (Teijin)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameCCR2 antagonists (Teijin)
Drug Alias NameCCR2 antagonists (DuPont/Teijin)MCP-1 antagonists (DuPont/Teijin)MCP1 antagonists (Teijin)anti-inflammatories (DuPont/Teijin)antiinflammatories (Teijin/BMS) +[12] 
ClassificationSmall molecules
Mechanisms of ActionMembrane cofactor protein inhibitorsC-C chemokine receptor type 2 antagonists
TargetsMembrane cofactor proteinC-C chemokine receptor type 2
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDeltagen Research Laboratories LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTeijin PharmaDeltagen Research Laboratories LLCBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A